Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pituitary
Published in: Pituitary 4/2003

01-12-2003

Proteomics and Transcriptomics Analyses of Secretagogin Down-Regulation in Human Non-Functional Pituitary Adenomas

Authors: Xianquan Zhan, Chheng-Orn Evans, Nelson M. Oyesiku, Dominic M. Desiderio

Published in: Pituitary | Issue 4/2003

Login to get access
Metadata
Title
Proteomics and Transcriptomics Analyses of Secretagogin Down-Regulation in Human Non-Functional Pituitary Adenomas
Authors
Xianquan Zhan
Chheng-Orn Evans
Nelson M. Oyesiku
Dominic M. Desiderio
Publication date
01-12-2003
Publisher
Kluwer Academic Publishers
Published in
Pituitary / Issue 4/2003
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1023/B:PITU.0000023426.99808.40

Other articles of this Issue 4/2003

Pituitary 4/2003 Go to the issue

OriginalPaper

Coexistence of a Pituitary Macroadenoma and Pheochromocytoma—A Case Report and Review of the Literature

OriginalPaper

Sustained Improvement in Vision in a Recurrent Growth Hormone Secreting Macroadenoma During Treatment with Octreotide in the Absence of Marked Tumour Shrinkage

OriginalPaper

Acromegalic Cardiomyopathy: A Review of the Literature

OriginalPaper

Serial MR Intensity Changes of the Posterior Pituitary in Patients with Diabetes Insipidus After Transsphenoidal Surgery for Pituitary Adenomas: Report of Two Cases

OriginalPaper

Basal and Glucose-Suppressed GH Levels Less Than 1 μg/L in Newly Diagnosed Acromegaly

OriginalPaper

Sheehan's Syndrome
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits